[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367757-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367757-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-burden-of-proof-study-of-the-effects-of-exposure-to-high-fasting-plasma-glucose-on-the-risk-of-seven-types-of-cancer","A burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancer","","Cancer burden is shaped by genetics and aging, but modifiable risk factors account for a meaningful share. A systematic review and meta-analysis quantified and assessed how high fasting plasma glucose (FPG) relates to developing and dying from seven cancer types selected for attributable burden from FPG in the GBD. Using Burden of Proof methods, the study found moderate associations with breast, pancreatic, and colorectal cancers, and weaker associations with bladder, liver, ovarian, and tracheal/bronchus/lung cancers, informing potential impacts of hypoglycemic treatments.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-burden-of-proof-study-of-the-effects-of-exposure-to-high-fasting-plasma-glucose-on-the-risk-of-seven-types-of-cancer/367757/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-burden-of-proof-study-of-the-effects-of-exposure-to-high-fasting-plasma-glucose-on-the-risk-of-seven-types-of-cancer/367757.png","ImageObject",300,407,{"name":42,"@type":43},"Mabel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of the Burden of Proof study?","Question",{"text":63,"@type":64},"To quantify and evaluate the relationship between high fasting plasma glucose (FPG) levels and the risk of developing and dying from seven types of cancer using conservative Burden of Proof interpretation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cancer types showed moderate versus weak relationships with high FPG?",{"text":68,"@type":64},"Moderate relationships were found for breast, pancreatic, and colorectal cancer. Weak relationships were observed for bladder, liver, ovarian, and tracheal, bronchus, and lung cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"How did the study translate Burden of Proof results into a more usable metric?",{"text":72,"@type":64},"It converted the burden of proof risk function (BPRF) into a risk-outcome score (ROS) mapped onto a star-rating scale, reflecting both association magnitude and evidence strength for each cancer type.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367757,1790463191,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nA burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancer  \nPaula Portal Teixeira2,4􀀍, Yvonne Yiru Xu1,4, Aleksandr Aravkin1, Peng Zheng1, Lisa M. Force1, Jonathan Kocarnik1, Susan McLaughlin1, Theo Vos1, Hailey Lenox1, Simon I. Hay1, Bruce Bartholow Duncan2, Verônica Colpani3, Chris Murray1, Fernando Gerchman2 & Kanyin Liane Ong1  \nCancer is a major public health problem strongly influenced by genetic factors and aging; however, a proportion of its burden can be attributed to potentially modifiable risk factors. We undertook a systematic review and meta-analysis of the existing evidence to quantify and assess the relationship between high fasting plasma glucose (FPG) levels and the risk of developing and dying for seven types of cancer (selected for having attributable burden from FPG inGBD). Using Burden of Proof methods that provide a conservative interpretation of the evidence, we found moderate relationships between high FPG and the risk of breast, pancreatic, and colorectal cancer. Weak relationships were observed with bladder, liver, ovarian, and tracheal, bronchus and lung cancers. These findings should galvanize the global community’s efforts in addressing the increasing burden of high blood sugar and inform the potential impact of different hypoglycemic treatments on reducing the burden of cancer.  \nCancer is a major public health problem and one of the leading causes of death globally, responsible for 9.83 million (95% uncertainty interval (UI) 9.07–10.52) deaths and 252.09 million (236.33–269.34) disabilityadjusted life years (DALYs) in 20211,2. Between 2010 and 2019, the number of new cancer cases and deaths globally increased by 26.3% and 20.9%3, respectively, and, based on the GLOBOCAN estimates produced by the International Agency for Research on Cancer, a 47% increase in new cases is projected by 2040 if the rise is not checked4. According to the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) from 2021, the five leading causes of cancer-related DALYs were tracheal, bronchus and lung cancer, colorectal cancer (CRC), stomach cancer, breast cancer, and esophageal cancer1,2. Although cancer risk is strongly influenced by genetic factors and aging, a significant proportion of cancer burden can be attributed to potentially modifiable risk factors, such as smoking, excess body weight, and dietary factors5.  \nBased on recent GBD estimates from 2021, high levels of fasting plasma glucose (FPG) had an increasing global impact on health. High FPG and high body mass index (BMI) were the only two risk factors that increased in age-standardized attributable DALYs rates between 2000 and 2021, which contrasted with decreases over the same period for all the other leading 25 GBD Level 3 risk factors6. High FPG has been shown to be associated with an increased risk of cancer and contribute to its progression and mortality7,8with the estimated magnitude of association varying by cancer type9. Studies have suggested that liver and pancreatic cancers have a higher incidence and higher risk of mortality in people with diabetes mellitus (DM)8, 10. In 2021, high FPG was oneof the top five leading risk factors for cancer, contributing 2.8%(0.3–5.4) of risk-attributable cancer DALYs1,2. However, while most studies assessing the potential effect of glucose levels on cancer burden have highlighted DM-or prediabetes-associated cancer incidence and mortality11there are inconsistent findings related to whether there is a dose-response relationship between increasing levels ofFPG and the risk of different cancer types12.  \nIn this study, which is part ofGBD 2021, we conducted a systematic review and meta-analysis using Burden of Proof (BoP) methods13 to quantify and describe the relationship between FPG levels along the blood glucose continuum and the risk of seven types of cancer: bl","cbCaijX31NSSMhSU","https://ap.wps.com/l/cbCaijX31NSSMhSU","pdf",1610387,15,"English","# Results\n## Overview","[{\"question\":\"What was the purpose of the Burden of Proof study?\",\"answer\":\"To quantify and evaluate the relationship between high fasting plasma glucose (FPG) levels and the risk of developing and dying from seven types of cancer using conservative Burden of Proof interpretation.\"},{\"question\":\"Which cancer types showed moderate versus weak relationships with high FPG?\",\"answer\":\"Moderate relationships were found for breast, pancreatic, and colorectal cancer. Weak relationships were observed for bladder, liver, ovarian, and tracheal, bronchus, and lung cancers.\"},{\"question\":\"How did the study translate Burden of Proof results into a more usable metric?\",\"answer\":\"It converted the burden of proof risk function (BPRF) into a risk-outcome score (ROS) mapped onto a star-rating scale, reflecting both association magnitude and evidence strength for each cancer type.\"}]","A burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancer | PDF",1790172423,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1d5b5cb02b31f1ded8d20449ca0d17f.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4675dbfc2cff6a76d75c79dedae53266.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6c82497a8d48bf828db79d3b02198ef.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11aad981de7638436f1e9287413f118c.webp",980,1287]